Skip to main content
Equibles

UBS Group AG

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1610520 ZURICH, V8
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,459,733
+$6,026,580 QoQ
Shares Held
206,070
+375.5% QoQ
Ownership
0.633%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 69% Shared 0% None 31%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. COLL ranks #24 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
 2,140,065 $72,505,400

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,459,733 206,070
2026-03-31 $1,433,153 43,337
2025-12-31 $4,439,567 95,887
2025-09-30 $8,938,509 255,459
2025-06-30 $6,831,733 231,036
2025-03-31 $6,463,449 216,531
2024-12-31 $5,744,810 200,517
2024-09-30 $1,399,578 36,221
2024-06-30 $749,389 23,273
2024-03-31 $1,226,750 31,601
2023-12-31 $97,664 3,173
2023-09-30 $60,299 2,698
2023-06-30 $247,049 11,496
2023-03-31 $235,365 9,811
2022-12-31 $46,284 1,995
2022-09-30 $56,966 3,556
2022-06-30 $15,753 889
2022-03-31 $37,442 1,839
2021-12-31 $57,944 3,102
2021-09-30 $79,848 4,045
2021-06-30 $375,663 15,891
2021-03-31 $457,694 19,312
2020-12-31 $307,480 15,351
2020-09-30 $101,226 4,862
2020-06-30 $333,969 19,084
2020-03-31 $371,327 22,739